408 related articles for article (PubMed ID: 20226336)
1. Mechanisms of carbapenem resistance among a collection of Enterobacteriaceae clinical isolates in a Texas city.
Bennett JW; Mende K; Herrera ML; Yu X; Lewis JS; Wickes BL; Jorgensen JH; Murray CK
Diagn Microbiol Infect Dis; 2010 Apr; 66(4):445-8. PubMed ID: 20226336
[TBL] [Abstract][Full Text] [Related]
2. Doripenem activity tested against a global collection of Enterobacteriaceae, including isolates resistant to other extended-spectrum agents.
Mendes RE; Rhomberg PR; Bell JM; Turnidge JD; Sader HS
Diagn Microbiol Infect Dis; 2009 Apr; 63(4):415-25. PubMed ID: 19249175
[TBL] [Abstract][Full Text] [Related]
3. Plasmid profile of ESBL producing Gram-negative bacteria and correlation with susceptibility to beta-lactam drugs.
Sharma J; Ray P; Sharma M
Indian J Pathol Microbiol; 2010; 53(1):83-6. PubMed ID: 20090229
[TBL] [Abstract][Full Text] [Related]
4. [Mechanisms of resistance in Enterobacteriaceae towards beta-lactamase antibiotics].
Susić E
Acta Med Croatica; 2004; 58(4):307-12. PubMed ID: 15700687
[TBL] [Abstract][Full Text] [Related]
5. Development of a set of multiplex PCR assays for the detection of genes encoding important beta-lactamases in Enterobacteriaceae.
Dallenne C; Da Costa A; Decré D; Favier C; Arlet G
J Antimicrob Chemother; 2010 Mar; 65(3):490-5. PubMed ID: 20071363
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and molecular characterization of clinical isolates of Escherichia coli expressing an AmpC phenotype.
Jørgensen RL; Nielsen JB; Friis-Møller A; Fjeldsøe-Nielsen H; Schønning K
J Antimicrob Chemother; 2010 Mar; 65(3):460-4. PubMed ID: 20097787
[TBL] [Abstract][Full Text] [Related]
7. Multiresistant Enterobacteriaceae: new threat of an old problem.
Pitout JD
Expert Rev Anti Infect Ther; 2008 Oct; 6(5):657-69. PubMed ID: 18847404
[TBL] [Abstract][Full Text] [Related]
8. A simple disc diffusion method for detecting AmpC and extended-spectrum beta-lactamases in clinical isolates of Enterobacteriaceae.
Derbyshire H; Kay G; Evans K; Vaughan C; Kavuri U; Winstanley T
J Antimicrob Chemother; 2009 Mar; 63(3):497-501. PubMed ID: 19155228
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and antimicrobial susceptibility data for extended-spectrum beta-lactamase- and AmpC-producing Enterobacteriaceae from the MYSTIC Program in Europe and the United States (1997-2004).
Goossens H; Grabein B
Diagn Microbiol Infect Dis; 2005 Dec; 53(4):257-64. PubMed ID: 16360549
[TBL] [Abstract][Full Text] [Related]
10. Breakpoints for extended-spectrum beta-lactamase-producing Enterobacteriacae: pharmacokinetic/pharmacodynamic considerations.
MacGowan A
Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():166-8. PubMed ID: 18154541
[TBL] [Abstract][Full Text] [Related]
11. Assessment of extended-spectrum β-lactamase, KPC carbapenemase and porin resistance mechanisms in clinical samples of Klebsiella pneumoniae and Enterobacter spp.
Jaskulski MR; Medeiros BC; Borges JV; Zalewsky R; Fonseca ME; Marinowic DR; Rocha MP; Nodari P; Machado DC
Int J Antimicrob Agents; 2013 Jul; 42(1):76-9. PubMed ID: 23664677
[TBL] [Abstract][Full Text] [Related]
12. A novel OXA-10-like beta-lactamase is present in different Enterobacteriaceae.
Porto A; Ayala J; Gutkind G; Di Conza J
Diagn Microbiol Infect Dis; 2010 Feb; 66(2):228-9. PubMed ID: 19833470
[TBL] [Abstract][Full Text] [Related]
13. What remains against carbapenem-resistant Enterobacteriaceae? Evaluation of chloramphenicol, ciprofloxacin, colistin, fosfomycin, minocycline, nitrofurantoin, temocillin and tigecycline.
Livermore DM; Warner M; Mushtaq S; Doumith M; Zhang J; Woodford N
Int J Antimicrob Agents; 2011 May; 37(5):415-9. PubMed ID: 21429716
[TBL] [Abstract][Full Text] [Related]
14. In vivo development of carbapenem resistance in clinical isolates of Enterobacter aerogenes producing multiple beta-lactamases.
Chen YG; Zhang Y; Yu YS; Qu TT; Wei ZQ; Shen P; Li LJ
Int J Antimicrob Agents; 2008 Oct; 32(4):302-7. PubMed ID: 18556176
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of plasmid-mediated AmpC beta-lactamases among Enterobacteriaceae in Algiers hospitals.
Iabadene H; Messai Y; Ammari H; Alouache S; Verdet C; Bakour R; Arlet G
Int J Antimicrob Agents; 2009 Oct; 34(4):340-2. PubMed ID: 19570655
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of methods to identify the Klebsiella pneumoniae carbapenemase in Enterobacteriaceae.
Anderson KF; Lonsway DR; Rasheed JK; Biddle J; Jensen B; McDougal LK; Carey RB; Thompson A; Stocker S; Limbago B; Patel JB
J Clin Microbiol; 2007 Aug; 45(8):2723-5. PubMed ID: 17581941
[TBL] [Abstract][Full Text] [Related]
17. Porin alterations present in non-carbapenemase-producing Enterobacteriaceae with high and intermediate levels of carbapenem resistance in Chile.
Wozniak A; Villagra NA; Undabarrena A; Gallardo N; Keller N; Moraga M; Román JC; Mora GC; García P
J Med Microbiol; 2012 Sep; 61(Pt 9):1270-1279. PubMed ID: 22700549
[TBL] [Abstract][Full Text] [Related]
18. Antimicrobial susceptibility of clinical isolates of Enterobacteriaceae producing complex beta-lactamase patterns including extended-spectrum enzymes.
Segatore B; Setacci D; Perilli M; Franchino L; Franceschini N; Agnifili A; Rossolini GM; Amicosante G
Int J Antimicrob Agents; 2004 May; 23(5):480-6. PubMed ID: 15120727
[TBL] [Abstract][Full Text] [Related]
19. A simple phenotypic method for the differentiation of metallo-beta-lactamases and class A KPC carbapenemases in Enterobacteriaceae clinical isolates.
Tsakris A; Poulou A; Pournaras S; Voulgari E; Vrioni G; Themeli-Digalaki K; Petropoulou D; Sofianou D
J Antimicrob Chemother; 2010 Aug; 65(8):1664-71. PubMed ID: 20542902
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of ertapenem resistance in Enterobacteriaceae isolates in a tertiary university hospital.
Chung HS; Yong D; Lee M
J Investig Med; 2016 Jun; 64(5):1042-9. PubMed ID: 27101841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
